Skip to main content
SNDX logo

SNDX · Syndax Pharmaceuticals Inc · Analyst Estimates

Track SNDX — free
$8.72 -0.41 (-4.49%) At close · Nov 20 Play latest call Q2 2026 earnings call transcript
Market Cap
$778.67M
Shares
89.30M
Volume · Nov 20 2.18M Avg daily vol (3M) 2.61M

Analyst Estimates

Compare analyst forecasts for Syndax Pharmaceuticals Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-20 11:12 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.24
-2.05
-1.79
9
-2.13
-1.98
-1.93
-1.93
— —
1
1
Revenue
USD
Publication date not stated
308.83M
315.93M
332.89M
10
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.36
-0.65
0.40
11
-0.78
-0.84
-0.82
-0.82
1
2
— —
Revenue
USD
Publication date not stated
397.00M
458.30M
614.97M
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.61
-0.44
-0.20
11
-0.50
-0.45
-0.43
-0.43
2
3
— —
Revenue
USD
Publication date not stated
87.88M
95.79M
127.88M
11
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.42
-0.26
-0.081
4
-0.28
-0.082
-0.072
-0.072
0
1
— —
Revenue
USD
Publication date not stated
95.30M
95.95M
96.61M
2
— — — — — — — —
Key facts CIK 1395937 CUSIP 87164F105 13F (30d) 241 filings 222 filers Visit website Investor relations